Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Aquablation outcomes for the U.S. cohort of men with LUTS due to BPH in large prostates (80–150 cc)

Abstract

Between September and December 2017, 82 men with moderate-to-severe lower urinary tract symptoms due to benign prostatic hyperplasia LUTS/BPH and prostate volume of 80–150 cc underwent Aquablation in a prospective multicenter clinical trial in the United States. Baseline patient and clinical demographics and standardized postoperative parameters were collected and tabulated in a central independently monitored database. Adverse events through 3 months were adjudicated by an independent clinical events committee. Mean pre-treatment prostate volume was 108 ± 21.1 cc. Mean operative time was 38.2 ± 14.4 min and mean Aquablation resection time was 7.7 ± 3.3 min. Additional electrocautery for hemostasis was not needed in any patient following Aquablation. The average length of stay following the procedure was 1.6 ± 1.0 days. Mean pre- and 3 months post-treatment IPSS scores were 23.7 ± 6.4 and 7.1 ± 5.1, –16.6, p < 0.01. Mean pre- and 3 months post-treatment Qmax were 9.2 ± 3.3 ml/s and 19.5 ± 13 ml/s, + 10.8 ml/s, p < 0.01. Mean pre- and 3 months post-treatment post-void residuals were 120.6 ± 119.1 cc and 50.6 ± 61.6 cc, –72.0 cc, p < 0.01. The observed Clavien-Dindo grade 2 or higher event rate at 3 months was 34.1%. Aquablation is a safe and effective treatment option for men with large prostates (80–150 cc) suffering from LUTS/BPH.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1

Similar content being viewed by others

Richard J. Rebello, Christoph Oing, … Robert G. Bristow

References

  1. Wei JT, Calhoun E, Jacobsen SJ. Urologic diseases in America project: benign prostatic hyperplasia. J Urol. 2005;173:1256–61.

    Article  PubMed  Google Scholar 

  2. McVary KT. BPH: epidemiology and comorbidities. Am J Manag Care. 2006;12(5 Suppl):S122–8.

    PubMed  Google Scholar 

  3. McVary KT, Roehrborn CG, Avins AL, Barry MJ, Bruskewitz RC, Donnell RF, et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol. 2011;185:1793–803.

    Article  PubMed  Google Scholar 

  4. American Urological Association—Adult Urodynamics: AUA/SUFU Guideline [Internet]. [cited 3 Jul 3 2017]. Available from: https://www.auanet.org/guidelines/urodynamics. 2012

  5. Ferretti M, Phillips J. Prostatectomy for benign prostate disease: open, laparoscopic and robotic techniques. Can J Urol. 2015;22(Suppl 1):60–6.

    PubMed  Google Scholar 

  6. Pariser JJ, Pearce SM, Patel SG, Bales GT. National trends of simple prostatectomy for benign prostatic hyperplasia with an analysis of risk factors for adverse perioperative outcomes. Urology . 2015;86:721–6.

    Article  PubMed  Google Scholar 

  7. Pariser JJ, Packiam VT, Adamsky MA, Bales GT. Trends in simple prostatectomy for benign prostatic hyperplasia. Curr Urol Rep. 2016;17:57.

    Article  PubMed  Google Scholar 

  8. Valdivieso R, Hueber P-A, Meskawi M, Belleville E, Ajib K, Bruyere F, et al. Multicenter international experience of 180W LBO laser photo-vaporization in men with extremely large prostates (prostate volume > 200 cc): Is there a size limit? Br J Urol. 2018 (In Press)

  9. Hueber P-A, Bienz MN, Valdivieso R, Lavigueur-Blouin H, Misrai V, Rutman M, et al. Photoselective vaporization of the prostate for benign prostatic hyperplasia using the 180 watt system: Multicenter study of the impact of prostate size on safety and outcomes. J Urol. 2015;194:462–9.

    Article  PubMed  Google Scholar 

  10. Brunckhorst O, Ahmed K, Nehikhare O, Marra G, Challacombe B, Popert R. Evaluation of the learning curve for holmium laser enucleation of the prostate using multiple outcome measures. Urology . 2015;86:824–9.

    Article  PubMed  Google Scholar 

  11. Robert G, Cornu J-N, Fourmarier M, Saussine C, Descazeaud A, Azzouzi A-R, et al. Multicentre prospective evaluation of the learning curve of holmium laser enucleation of the prostate (HoLEP). BJU Int. 2016;117:495–9.

    Article  PubMed  Google Scholar 

  12. Gilling P, Reuther R, Kahokehr A, Fraundorfer M. Aquablation—image-guided robot-assisted waterjet ablation of the prostate: initial clinical experience. BJU Int. 2016;117:923–9.

    Article  CAS  PubMed  Google Scholar 

  13. Gilling P, Anderson P, Tan A. Aquablation of the prostate for symptomatic benign prostatic hyperplasia: 1-year results. J Urol. 2017;197:1565–72.

    Article  PubMed  Google Scholar 

  14. Gilling PJ, Barber NJ, Bidair M, Anderson P. WATER—A double-blind randomized controlled trial of aquablation vs. transurethral resection of the prostate in benign prostatic hyperplasia. J Urol. 2018;199:1252–1261.

  15. Desai M. Bidair M, Bhojani N. WATER II Aquablation procedural outcomes for BPH in large prostates (80–150cc): Initial experience. Br J Urol. 2018 (In Press).

  16. R Core Team. R: A language and environment for statistical computing [Internet]. Vienna, Austria: R foundation for statistical computing; 2016. Available from: https://www.R-project.org/

  17. Gratzke C, Schlenker B, Seitz M, Karl A, Hermanek P, Lack N, et al. Complications and early postoperative outcome after open prostatectomy in patients with benign prostatic enlargement: results of a prospective multicenter study. J Urol. 2007;177:1419–22.

    Article  PubMed  Google Scholar 

  18. Lanchon C, Fiard G, Long J-A, Arnoux V, Carnicelli D, Franquet Q, et al. Open prostatectomy versus 180-W XPS GreenLight laser vaporization: Long-term functional outcome for prostatic adenomas > 80g. Prog En Urol [Internet]. 2018 Jan 10 [cited 2018 Jan 20]; Available from: http://www.sciencedirect.com/science/article/pii/S1166708717306826

  19. Hueber P-A, Liberman D, Ben-Zvi T, Woo H, Hai MA, Te AE, et al. 180 W vs 120 W lithium triborate photoselective vaporization of the prostate for benign prostatic hyperplasia: a global, multicenter comparative analysis of perioperative treatment parameters. Urology. 2013;82:1108–13.

    Article  PubMed  Google Scholar 

  20. Montorsi F, Naspro R, Salonia A, Suardi N, Briganti A, Zanoni M, et al. Holmium laser enucleation versus transurethral resection of the prostate: results from a 2-center, prospective, randomized trial in patients with obstructive benign prostatic hyperplasia. J Urol. 2004;172(5 Pt 1):1926–9.

    Article  PubMed  Google Scholar 

  21. Kuo RL, Paterson RF, Siqueira TM, Watkins SL, Simmons GR, Steele RE, et al. Holmium laser enucleation of the prostate: morbidity in a series of 206 patients. Urology . 2003;62:59–63.

    Article  PubMed  Google Scholar 

  22. Bachmann A, Tubaro A, Barber N, d’Ancona F, Muir G, Witzsch U, et al. 180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European Multicentre Randomised Trial--the GOLIATH study. Eur Urol. 2014;65:931–42.

    Article  PubMed  Google Scholar 

  23. Kuntz RM, Ahyai S, Lehrich K, Fayad A. Transurethral holmium laser enucleation of the prostate versus transurethral electrocautery resection of the prostate: a randomized prospective trial in 200 patients. J Urol. 2004;172:1012–6.

    Article  PubMed  Google Scholar 

  24. Tan AHH, Gilling PJ, Kennett KM, Frampton C, Westenberg AM, Fraundorfer MR. A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams). J Urol. 2003;170(4 Pt 1):1270–4.

    Article  CAS  PubMed  Google Scholar 

  25. Krambeck AE, Handa SE, Lingeman JE. Experience with more than 1,000 holmium laser prostate enucleations for benign prostatic hyperplasia. J Urol. 2013;189(1 Suppl):S141–5.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The study was funded by PROCEPT BioRobotics.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Faysal A. Yafi.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yafi, F.A., Tallman, C.T., Seard, M.L. et al. Aquablation outcomes for the U.S. cohort of men with LUTS due to BPH in large prostates (80–150 cc). Int J Impot Res 30, 209–214 (2018). https://doi.org/10.1038/s41443-018-0045-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41443-018-0045-3

This article is cited by

Search

Quick links